InvestorsHub Logo
Followers 0
Posts 35
Boards Moderated 0
Alias Born 07/24/2008

Re: apostle1313 post# 1414

Wednesday, 11/26/2008 1:28:25 PM

Wednesday, November 26, 2008 1:28:25 PM

Post# of 11073
1)I think there needs to be independent audting and SEC filings
2)I think that Rebuilder Medical Technologies needs to submit to the FDA the new clinical proof of the medical claims its devices provide so they can brand and label products accordingly. (i.e. helping neuropathy by x,y,z factors)

I don't know how much each of these items would cost. If its a few thousand a quarter, then it should have already been done. If both of these things are not done, there will not be enough serious investors to counter the shorts.
Additionally, if it's not cost-prohibitive and items 1 & 2 are not done, it could be construed that there is no truth or 'half-truths' to accounting practices and the product itself. So the question still stands.......why are these things not done?